Actual Medicinal Product (AMP) -
Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials (Pfizer Ltd)
Name Details
|
Current Name
Comirnaty KP.2 adults and adolescents from 12 years COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection multidose vials
|
Start Date
11-12-2024
|
End Date
|
|
|
Abbreviated Name
Comirnaty KP.2 COVID-19 Vacc 30microg/0.3ml dose inj md vial
|
Start Date
11-12-2024
|
|
Summary
- Licensed Route
- Intramuscular
- Availability Restrictions
- Restricted Availability
- Licensing Authority
- Medicines - MHRA/EMA
- EMA Indicator
- EMA Monitoring
Codes
SNOMED Codes
|
Code
|
Start Date
|
End Date
|
| 44145611000001106 |
11-12-2024 |
|
Actual Medicinal Product Pack (AMPP) Information